An immune-related six-lncRNA signature to improve prognosis prediction of glioblastoma multiforme
Recent studies have demonstrated the utility and superiority of long non-coding RNAs
(lncRNAs) as novel biomarkers for cancer diagnosis, prognosis, and therapy. In the present …
(lncRNAs) as novel biomarkers for cancer diagnosis, prognosis, and therapy. In the present …
An immune-related lncRNA signature to predict survival in glioma patients
P Xia, Q Li, G Wu, Y Huang - Cellular and molecular neurobiology, 2021 - Springer
Glioma is the most common and fatal primary brain tumor in human. Long non-coding RNA
(lncRNA), which are characterized by regulation of gene expression and chromatin …
(lncRNA), which are characterized by regulation of gene expression and chromatin …
A long non-coding RNA signature in glioblastoma multiforme predicts survival
Long non-coding RNAs (lncRNAs) represent the leading edge of cancer research, and have
been implicated in cancer biogenesis and prognosis. We aimed to identify lncRNA …
been implicated in cancer biogenesis and prognosis. We aimed to identify lncRNA …
Analysis of long non-coding RNAs in glioblastoma for prognosis prediction using weighted gene co-expression network analysis, Cox regression, and L1-LASSO …
R Liang, Y Zhi, G Zheng, B Zhang, H Zhu… - OncoTargets and …, 2018 - Taylor & Francis
Purpose This study focused on identification of long non-coding RNAs (lncRNAs) for
prognosis prediction of glioblastoma (GBM) through weighted gene co-expression network …
prognosis prediction of glioblastoma (GBM) through weighted gene co-expression network …
Machine learning-based tumor-infiltrating immune cell-associated lncRNAs for predicting prognosis and immunotherapy response in patients with glioblastoma
Long noncoding ribonucleic acids (RNAs; lncRNAs) have been associated with cancer
immunity regulation. However, the roles of immune cell-specific lncRNAs in glioblastoma …
immunity regulation. However, the roles of immune cell-specific lncRNAs in glioblastoma …
Identification of immune-related lncRNA prognostic signature and molecular subtypes for glioblastoma
W Yu, Y Ma, W Hou, F Wang, W Cheng, F Qiu… - Frontiers in …, 2021 - frontiersin.org
Background Glioblastoma multiforme (GBM) is extensively genetically and transcriptionally
heterogeneous, which poses challenges for classification and management. Long …
heterogeneous, which poses challenges for classification and management. Long …
Expression of lncRNAs in low-grade gliomas and glioblastoma multiforme: an in silico analysis
Background Each year, over 16,000 patients die from malignant brain cancer in the US.
Long noncoding RNAs (lncRNAs) have recently been shown to play critical roles in …
Long noncoding RNAs (lncRNAs) have recently been shown to play critical roles in …
Long non-coding RNA expression profiles predict clinical phenotypes in glioma
X Zhang, S Sun, JKS Pu, ACO Tsang, D Lee… - Neurobiology of …, 2012 - Elsevier
Glioma is the commonest form of primary brain tumor in adults with varying malignancy
grades and histological subtypes. Long non-coding RNAs (lncRNAs) are a novel class of …
grades and histological subtypes. Long non-coding RNAs (lncRNAs) are a novel class of …
Survival analysis of immune-related lncRNA in low-grade glioma
X Li, Y Meng - BMC cancer, 2019 - Springer
Background Low-grade glioma is grade I-II glioma. Immunotherapy is a promising way of
tumor killing. Research on immune molecular mechanisms in low-grade gliomas and …
tumor killing. Research on immune molecular mechanisms in low-grade gliomas and …
Long non-coding RNAs in diagnosis, treatment, prognosis, and progression of glioma: a state-of-the-art review
S Momtazmanesh, N Rezaei - Frontiers in oncology, 2021 - frontiersin.org
Glioma is the most common malignant central nervous system tumor with significant
mortality and morbidity. Despite considerable advances, the exact molecular pathways …
mortality and morbidity. Despite considerable advances, the exact molecular pathways …